top of page

SELECT PUBLICATIONS

Transparent research that is rigorously peer-reviewed

MTPPI strives to incorporate the principles of open science into all Institute research policies and activities. We work to proactively share our results and findings with the public and we make all of our methods and research tools available through open source dissemination channels. Our researchers are invited to present at various scientific meetings throughout the year and MTPPI also hosts research dissemination webinars that are open to the public and free to attend.

Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection

Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?

Who Is at Risk for New Hepatitis B Infections Among People With HIV?

Publication in JCE

Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment

Health technology assessment: decentralized and fragmented in the US compared to other countries

Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems

Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems

Unequal access to cadaveric kidney transplantation in California based on insurance status

Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991

Translating epoetin research into practice: the role of government and the use of scientific evidence

Risky business: long-term care insurance underwriting

Health insurance coverage among foreign-born US residents: the impact of race, ethnicity, and length of residence

Race, income, urbanicity, and asthma hospitalization in California: a small area analysis

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas

Prednisone, lupus activity, and permanent organ damage

Implementing Advance Care Planning for dialysis patients: HIGHway project

Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the U.S.

Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation

The effect of dialysis chains on mortality among patients receiving hemodialysis

High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes

Organizational Status of Dialysis Facilities and Patient Outcome: Does Higher Injectable Medication Use Mediate Increased Mortality?

bottom of page